Previous Close | 167.23 |
Open | 170.45 |
Bid | 167.92 x 800 |
Ask | 167.35 x 1100 |
Day's Range | 166.96 - 171.69 |
52 Week Range | 144.80 - 201.92 |
Volume | |
Avg. Volume | 3,678,629 |
Market Cap | 76.233B |
Beta (5Y Monthly) | 0.85 |
PE Ratio (TTM) | 32.13 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.73 (1.03%) |
Ex-Dividend Date | Apr 18, 2024 |
1y Target Est | N/A |
PARSIPPANY, N.J., May 02, 2024--Zoetis Inc. (NYSE:ZTS) today reported its financial results for the first quarter of 2024 and updated its guidance for full year 2024.
PARSIPPANY, N.J. & TEANECK, N.J., April 28, 2024--Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
PARSIPPANY, N.J., April 25, 2024--As we celebrate World Veterinary Day, the Zoetis Foundation is proud to support veterinarians around the world today and everyday by providing grant support to initiatives promoting veterinary education, mental well-being, and livelihoods. Recognizing the invaluable role veterinarians and veterinary technicians play in advancing animal health, the Foundation is committed to helping cultivate a thriving, inclusive veterinary profession.